- Investing Ideas
- /
- French Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
French Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Eurofins Scientific
Market Cap: €10.8b
Provides various analytical testing and laboratory services worldwide.
ERF
€60.96
7D
-2.6%
1Y
5.3%
Sartorius Stedim Biotech
Market Cap: €16.7b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€171.55
7D
-7.8%
1Y
-10.6%